Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR   US00484M1062

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
30.71(c) 31.4(c) 31.95(c) 32.26(c) 32.01(c) Last
404 265 612 440 1 161 105 821 565 474 346 Volume
+2.23% +2.25% +1.75% +0.97% -0.77% Change
More quotes
Financials ($)
Sales 2015 449 M
EBIT 2015 8,18 M
Net income 2015 -22,4 M
Finance 2015 14,4 M
Yield 2015 -
Sales 2016 500 M
EBIT 2016 8,63 M
Net income 2016 -19,2 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 3,02x
Capi. / Sales 2016 2,74x
Capitalization 1 370 M
More Financials
Company
Acorda Therapeutics, Inc. engages in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system.The company's two main products are Ampyra and Zanaflex... 
More about the company
Surperformance© ratings of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACORDA THERAPEUTICS INC
05/14 ACORDA THERAPEUTICS : Reports First Quarter 2015 Financial Results
05/14 ACORDA THERAPEUTICS : to Present at the Bank of America Merrill Lynch 2015 Healt..
05/06 ACORDA THERAPEUTICS : to Participate at the Deutsche Bank 40th Annual Health Car..
05/05 ACORDA THERAPEUTICS : to Present at the Bank of America Merrill Lynch 2015 Healt..
05/05 ACORDA THERAPEUTICS : Posts First Quarter 2015 Financial Results
05/01 ACORDA THERAPEUTICS : to Present at the Deutsche Bank 40th Annual Health Care Co..
04/30 ACORDA THERAPEUTICS : reports 1Q loss
04/30 ACORDA THERAPEUTICS : Results of Operations and Financial Condition, Financial S..
More news
Sector news : Bio Therapeutic Drugs
05/22 SYNAGEVA BIOPHARMA : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investiga..
05/22 BLUEBIRD BIO : Announces Participation at the Jefferies 2015 Global Healthcare C..
05/21 ABBVIE : specifies breakdown of $21 billion Pharmacyclics deal
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/03 Acorda Therapeutics' (ACOR) CEO Ron Cohen Discusses on Q1 2015 Results - Earn..
05/01 ACORDA THERAPEUTICS : Will It Be Bought Out?
04/30 Acorda Therapeutics reiterates 2015 guidance after Q1 results
04/30 Acorda Therapeutics beats by $0.01, misses on revenue
04/29 Notable earnings before Thursday?s open


Comments 
Advertisement
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions